Literature DB >> 25004212

CAR-T cell therapy seeks strategies to harness cytokine storm.

Laura DeFrancesco.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25004212     DOI： 10.1038/nbt0714-604

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.

Authors:  Marco L Davila; Isabelle Riviere; Xiuyan Wang; Shirley Bartido; Jae Park; Kevin Curran; Stephen S Chung; Jolanta Stefanski; Oriana Borquez-Ojeda; Malgorzata Olszewska; Jinrong Qu; Teresa Wasielewska; Qing He; Mitsu Fink; Himaly Shinglot; Maher Youssif; Mark Satter; Yongzeng Wang; James Hosey; Hilda Quintanilla; Elizabeth Halton; Yvette Bernal; Diana C G Bouhassira; Maria E Arcila; Mithat Gonen; Gail J Roboz; Peter Maslak; Dan Douer; Mark G Frattini; Sergio Giralt; Michel Sadelain; Renier Brentjens
Journal:  Sci Transl Med       Date:  2014-02-19       Impact factor: 17.956
  1 in total
  21 in total

1.  Therapy-related acute myeloid leukemia in patients with lymphoma: A report of four cases and review of the literature.

Authors:  Dan Yang; Xiaorui Fu; Xudong Zhang; Wencai Li; Mingzhi Zhang
Journal:  Oncol Lett       Date:  2015-09-15       Impact factor: 2.967

Review 2.  Building better monoclonal antibody-based therapeutics.

Authors:  George J Weiner
Journal:  Nat Rev Cancer       Date:  2015-06       Impact factor: 60.716

3.  Developers seek to finetune toxicity of T-cell therapies.

Authors:  Chris Morrison
Journal:  Nat Biotechnol       Date:  2014-12       Impact factor: 54.908

4.  Natural killer cells blaze into immuno-oncology.

Authors:  Ken Garber
Journal:  Nat Biotechnol       Date:  2016-03       Impact factor: 54.908

5.  CAR-T cells forge ahead, Novartis reorganizes.

Authors:  Cormac Sheridan
Journal:  Nat Biotechnol       Date:  2016-11-08       Impact factor: 54.908

Review 6.  Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases.

Authors:  Karen M Wagner; Cindy B McReynolds; William K Schmidt; Bruce D Hammock
Journal:  Pharmacol Ther       Date:  2017-06-19       Impact factor: 12.310

7.  Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation.

Authors:  Lan Wu; Edward Seung; Ling Xu; Ercole Rao; Dana M Lord; Ronnie R Wei; Virna Cortez-Retamozo; Beatriz Ospina; Valeriya Posternak; Gregory Ulinski; Peter Piepenhagen; Elisa Francesconi; Nizar El-Murr; Christian Beil; Patrick Kirby; Aiqun Li; Jennifer Fretland; Rita Vicente; Gejing Deng; Tarik Dabdoubi; Beatrice Cameron; Thomas Bertrand; Paul Ferrari; Stéphanie Pouzieux; Cendrine Lemoine; Catherine Prades; Anna Park; Huawei Qiu; Zhili Song; Bailin Zhang; Fangxian Sun; Marielle Chiron; Srinivas Rao; Katarina Radošević; Zhi-Yong Yang; Gary J Nabel
Journal:  Nat Cancer       Date:  2019-11-18

Review 8.  Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment.

Authors:  Samaresh Sau; Hashem O Alsaab; Ketki Bhise; Rami Alzhrani; Ghazal Nabil; Arun K Iyer
Journal:  J Control Release       Date:  2018-01-31       Impact factor: 9.776

9.  Structure-tuned membrane active Ir-complexed oligoarginine overcomes cancer cell drug resistance and triggers immune responses in mice.

Authors:  Shuangshuang Ji; Xiuzhu Yang; Xiaolong Chen; Ang Li; Doudou Yan; Haiyan Xu; Hao Fei
Journal:  Chem Sci       Date:  2020-08-10       Impact factor: 9.825

10.  Ganoderma Lucidum Polysaccharides Enhance the Abscopal Effect of Photothermal Therapy in Hepatoma-Bearing Mice Through Immunomodulatory, Anti-Proliferative, Pro-Apoptotic and Anti-Angiogenic.

Authors:  Qing-Hai Xia; Cui-Tao Lu; Meng-Qi Tong; Meng Yue; Rui Chen; De-Li Zhuge; Qing Yao; He-Lin Xu; Ying-Zheng Zhao
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.